Effects of omeprazole: A Synthesis of Findings from 36 Studies
- Home
- Effects of omeprazole
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of omeprazole: A Synthesis of Findings from 36 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Findings
Omeprazole is a proton pump inhibitor that effectively suppresses gastric acid secretion. 23 , 13 , 32 , 36 , 8 , 20 , 33 , 21 , 1 , 11 , 27 , 7 , 25 , 10 , , 30 , 18 , 17 , 16 , 28 , 19 , 35 , 9 , 34 , 15 , 29 , 26 , 5 , 2 , 14 , 22 , , 31 , 6 , 12 , 4 Omeprazole has been shown to be effective in treating duodenal ulcers, promoting healing and reducing pain. 10 , 5 It is also used to treat Helicobacter pylori infection, leading to eradication of the bacteria. 20 , 25 , 27 , 14 , 31 Omeprazole is effective in treating gastroesophageal reflux disease. 32 , 29 Research has shown that omeprazole has comparable or superior acid suppression effects compared to other proton pump inhibitors. 31 , 30 Moreover, omeprazole provides long-lasting acid suppression effects. 13 , 1 , 33 Omeprazole may affect gastric motility. 6 Omeprazole increases gastric pH, making the stomach more alkaline by suppressing acid secretion. 11 Omeprazole can affect the absorption of other drugs. 23 , 25 , 18 , 22 Omeprazole can be administered orally or intravenously. 11 , 26 The dosage of omeprazole varies depending on the symptoms and disease. 12 , 5 Omeprazole has the potential to cause side effects. 10 , 14 Side effects are generally mild and often resolve upon discontinuation. 10 Long-term use of omeprazole has been linked to an increased risk of gastric carcinoid tumors. 10
Benefits and Risks
Benefits Summary
Omeprazole effectively suppresses gastric acid secretion, making it a valuable treatment for duodenal ulcers, gastroesophageal reflux disease, and Helicobacter pylori infection. Omeprazole has comparable or superior acid suppression effects compared to other proton pump inhibitors, and provides long-lasting acid suppression. It can be administered orally or intravenously, and the dosage is adjusted based on the individual's symptoms and disease.
Risks Summary
Omeprazole can cause side effects, although these are typically mild and tend to resolve upon stopping the medication. However, long-term use has been associated with an increased risk of gastric carcinoid tumors. It is important to understand these risks before using omeprazole.
Comparison Across Studies
Similarities Across Studies
Numerous studies have demonstrated that omeprazole effectively suppresses gastric acid secretion. The consistent findings across studies show that omeprazole is an effective treatment for duodenal ulcers, gastroesophageal reflux disease, and Helicobacter pylori infection.
Differences Across Studies
The dosage and administration method of omeprazole vary across different studies. The results on the effectiveness and side effects of omeprazole also differ across research. For example, some studies have shown a potential impact of omeprazole on gastric motility while others haven't found such an impact. Similarly, some studies indicate that omeprazole might affect the absorption of other medications, while others do not. While long-term use of omeprazole has been linked to a risk of gastric carcinoid tumors, not all studies have confirmed this association.
Consistency and Discrepancies in Findings
The effectiveness of omeprazole in suppressing gastric acid secretion is consistently demonstrated across multiple studies. However, there is variation in findings related to the potential side effects of omeprazole, particularly concerning long-term use. Further research is needed to fully understand the long-term effects of omeprazole.
Practical Considerations
While omeprazole effectively suppresses gastric acid secretion, it also carries potential risks. Understanding these risks and following the doctor's instructions for dosage and administration is crucial when using this medication. Regular consultations with a healthcare professional are important to monitor for potential side effects, particularly for individuals on long-term omeprazole treatment.
Limitations of Current Research
Some studies on omeprazole lack comprehensive assessments of the long-term side effects of its use. Additional research is required to better understand the impact of omeprazole on gastric motility, absorption of other drugs, and potential drug interactions.
Future Research Directions
Further research is essential to thoroughly investigate the long-term side effects associated with omeprazole use, its impact on gastric motility and drug absorption, and the potential interactions with other medications. A deeper understanding of these aspects is crucial for ensuring the safe and effective use of omeprazole.
Conclusion
Omeprazole is a valuable medication for effectively suppressing gastric acid secretion, making it a suitable treatment for duodenal ulcers, gastroesophageal reflux disease, and Helicobacter pylori infection. However, it's important to be aware of the potential risks associated with omeprazole, including side effects and the possibility of long-term complications. Consult your doctor before using omeprazole, and follow their instructions regarding dosage and administration. Continued research on omeprazole is important to better understand its long-term effects and potential interactions with other medications.
Benefit Keywords
Risk Keywords
Article Type
Author: ChivertonS G, HowdenC W, BurgetD W, HuntR H
Language : English
Author: BaakL C, BiemondI, JansenJ B, LamersC B
Language : English
Author: LauritsenK, AndersenB N, LaursenL S, HansenJ, HavelundT, EriksenJ, RehfeldJ F, KjaergaardJ, Rask-MadsenJ
Language : English
Author: GrahamD Y, McCulloughA, SklarM, SontagS J, RoufailW M, StoneR C, BishopR H, GitlinN, CagliolaA J, BermanR S
Language : English
Author: LauritsenK, AndersenB N, HavelundT, LaursenL S, HansenJ, EriksenJ, JørgensenT, Rask-MadsenJ
Language : English
Author: PedersenS A, KraglundK, Vinter-JensenL
Language : English
Author: HemeryP, GalmicheJ P, RozeC, IsalJ P, Bruley des VarannesS, LavignolleA, Le BodicL
Language : English
Author: MacGilchristA J, HowdenC W, KenyonC J, BeastallG H, ReidJ L
Language : English
Author: HowdenC W, DerodraJ K, BurgetD W, HuntR H
Language : English
Author: LauritsenK, RuneS J, BytzerP, KelbaekH, JensenK G, Rask-MadsenJ, BendtsenF, LindeJ, HøjlundM, AndersenH H
Language : English
Author: WaltR P, ReynoldsJ R, LangmanM J, SmartH L, KitchingmanG, SomervilleK W, HawkeyC J
Language : English
Author:
Language : English
Author: HetzelD J, ShearmanD J
Language : English
Author: LaineL, SteinC, NeilG
Language : English
Author: VerdúE F, FraserR, ArmstrongD, BlumA L
Language : English
Author: SavarinoV, MelaG S, ZentilinP, CutelaP, MeleM R, PerilliD, VassalloA, ZambottiA, MansiC, CelleG
Language : English
Author: SavarinoV, MelaG S, ZentilinP, CutelaP, MansiC, VassalloA, FranceschiM, MelaM R, DallortoE, CelleG
Language : English
Author: PommerienW, BraunM, IdströmJ P, WrangstadhM, LondongW
Language : English
Author: SavarinoV, MelaG S, ZentilinP, MeleM R, VigneriS, MansiC, CelleG
Language : English
Author: MiehlkeS, MannesG A, LehnN, HeleC, StolteM, BayerdörfferE
Language : English
Author: DelchierJ C, BenamouzigR, StanescuL, RopertA, VallotT, WirquinV, RoudotF, LamarqueD, HamelinB
Language : English
Author: DavidF L, Da SilvaC M, MendesF D, FerrazJ G, MuscaraM N, MorenoH, De NucciG, PedrazzoliJ
Language : English
Transfer of metronidazole to gastric juice: impact of Helicobacter pylori infection and omeprazole.
Author: CalafattiS A, dos SantosA, da SilvaC M, DeguerM, CarvalhoA F, MendesF D, FerrazJ G, BentoA P, PereiraA A, PiovesanaH, de NucciG, LernerF, PedrazzoliJ
Language : English
Author: BytzerP, AalykkeC, RuneS, WeywadtL, GjørupT, EriksenJ, BonnevieO, BekkerC, Kromann-AndersenH, KjaergaardJ, Rask-MadsenJ, VilienM, HansenJ, JustesenT, VybergM, TeglbjaergP S
Language : English
Author: PedrazzoliJ, CalafattiS A, OrtizR A, DiasF E, DeguerM, MendesF D, BentoA P, PereiraA A, PiovesanaH, FerrazJ G, LernerF, de NucciG
Language : English
The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
Author: AbeYasunobu, InamoriMasahiko, TogawaJun-Ichi, KikuchiTaisuke, MuramatsuKenichi, ChiguchiGaku, KawamuraHarunobu, KobayashiNoritoshi, KirikoshiHiroyuki, SakaguchiTakashi, TakamuraTomoo, NakajimaAtsushi, UenoNorio, SekiharaHisahiko
Language : English
Author: BefritsR, SjöstedtS, TourR, LeijonmarckC-E, HedenborgL, BackmanM,
Language : English
Author: CastellD, BaginR, GoldlustB, MajorJ, HepburnB
Language : English
Author: PaceF, AnneseV, PradaA, ZambelliA, CasaliniS, NardiniP, Bianchi PorroG,
Language : English
Author: ShimataniT, InoueM, KuroiwaT, XuJ, MienoH, TazumaS
Language : English
Author: WangXia, FangJing-Yuan, LuRong, SunDan-Feng
Language : English
Author: ShimataniTomohiko, InoueMasaki, KuroiwaTomoko, MoriwakiMutsuko, XuJing, IkawaKazuro, MorikawaNorifumi, TazumaSusumu
Language : English
Author: ShimataniTomohiko, KuroiwaTomoko, MoriwakiMutsuko, XuJing, TazumaSusumu, InoueMasaki
Language : English
Author: WoJ M, EversmannJ, MannS
Language : English
Author: IidaHiroshi, InamoriMasahiko, OkunoKotone, SekinoYusuke, SakaiEiji, OkuboHidenori, HigurashiTakuma, EndoHiroki, HosonoKunihiro, YonedaMasato, KoideTomoko, TakahashiHirokazu, GotoAyumu, KubotaKensuke, SaitoSatoru, MaedaShin, NakajimaAtsushi, GotohEiji
Language : English
Author: HwangJ-H, JeongJ-W, SongG-H, KooT-S, SeoK-W
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.